Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars
NCT ID: NCT00735254
Last Updated: 2018-02-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2008-07-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiplex Laser vs. PDL (Pulsed Dye Laser ) in the Treatment of Surgical Scars
NCT02472405
Surgical Scar Treatment With the Pulsed Dye Laser in Combination With a CO2 Laser
NCT02898350
Treatment of Post-Surgical Scars With Traditional Ablative Er:YAG Versus Fractional Ablative Er:YAG
NCT02397564
Effects of Pulsed-Dyed Laser on Scar Formation
NCT00852280
Treatment of Surgical Scars Using the Pulsed Dye Laser
NCT00970671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulsed dye laser
PDL Patient will be have scar treated with pulsed dye laser.
pulsed dye laser
patient will have scar treated with pulsed dye laser
Affirm laser
Patient will be have scar treated with Affirm Laser
Affirm Laser
patient will have scar treated with Affirm laser
combined PDL and Affirm Lasers
Patient will be have scar treated with combined Affirm + PDL
combined PDL and Affirm Lasers
patient will have scar treated with Affirm and pulsed dye lasers
Placebo
Patient will be have scar treated with Placebo
Placebo
patient will receive no treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulsed dye laser
patient will have scar treated with pulsed dye laser
Affirm Laser
patient will have scar treated with Affirm laser
combined PDL and Affirm Lasers
patient will have scar treated with Affirm and pulsed dye lasers
Placebo
patient will receive no treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No significant medical illness
* Surgical procedure that involves closure of the transverse abdominal incision performed in the department of dermatology and plastic surgery at the Cleveland Clinic main campus.
* Subjects with the willingness and ability to understand and provide informed consent
Exclusion Criteria
* Pregnancy or Lactation
* Subjects currently taking blood thinners or who have had chemotherapy or radiation within the last 6 months
* Subjects with liver/kidney disease, diabetes mellitus, hypertension, connective tissue disease or who are immunocompromised
* Subjects with a known susceptibility to keloid formation or hypertrophic scarring
* Subjects who are unable to understand the protocol or to give informed consent
* Subjects with mental illness
* Subjects with obvious non-healing wound
18 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Tung, MD
Role: STUDY_DIRECTOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinical Foundation
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-352
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.